Nav: Home

Scientists create successful mass production system for bioengineered livers

December 05, 2017

CINCINNATI - Researchers report creating a biologically accurate mass-production platform that overcomes major barriers to bioengineering human liver tissues suitable for therapeutic transplant into people.

A team led by the Cincinnati Children's Center for Stem Cell and Organoid Medicine (CuSTOM) and Yokohama City University in Japan report their findings Dec. 5 in Cell Reports. The study's lead investigator is Takanori Takebe, MD, a physician/investigator at both institutions.

The current study overcomes what have been nagging challenges for researchers working to bioengineer human organs that are safe and effective for therapeutic use, according to Takebe.

The new process allows researchers to bioengineer single batches of up to 20,000 genetically matched, three-dimensional and highly functional liver micro-buds. When combined, the batch has a sufficient quantity of liver cells and size feasibility for transplant into a person with liver failure, or for drug testing. The liver tissues were also generated entirely from human induced pluripotent stem cells (iPSCs), making the process free of animal feeder byproducts used to make cells for research purposes - a barrier to the cells being used therapeutically.

"Because we can now overcome these obstacles to generate highly functional, three-dimensional liver buds, our production process comes very close to complying with clinical-grade standards," explains Takebe. "The ability to do this will eventually allow us to help many people with final-stage liver disease. We want to save the lives of children who need liver transplants by overcoming the shortage of donor livers available for this."

The researchers stress continued research and refinement of their process is required before initial clinical trials could begin. Takebe estimates this might occur in the next two to five years.

Liver by Design

The work includes an international team of scientific and industrial collaborators, mostly in Japan and in Cincinnati. Takebe and colleagues over the past five years published several studies that made continuous progress into defining the precise genetic and molecular blueprints needed to mimic natural human development. This allows the researchers to develop and bioengineer functional, three-dimensional human mini livers in the laboratory.

To help overcome the biological challenge of animal-product feeder cells in the current study, Takebe and team used their fine-tuned formula of genetic and molecular components to generate the liver tissues in custom-designed, U-shaped bottom micro-well cell plates. The plates use a combination of chemistry techniques to form a finely structured film inside the micro-wells, designed to nurture the developing liver buds.

But prior to this step, the researchers started mass production by initially using the donor-derived iPSCs to grow three critical types of liver progenitor cells needed to generate healthy livers. These include hepatic endoderm cells and both endothelial and septum mesenchyme cells. Study data show this generates robust and highly functional progenitor cells that are placed into the custom-designed, film-coated micro-wells. The progenitor cells then engage in high levels of molecular cross-communication to form into self-organizing, three-dimensional liver buds.

The authors write that after they generated over 20,000 (liver) micro spots per well capable of reaching a scalable, therapeutically viable level, they tested the functionality of the three-dimensional tissues in genetically programmed mouse models of liver disease. The animals were rescued from liver disease by the highly functional organs.
-end-
About the Study

Among the many key collaborators on the study is co-author Hideki Taniguchi, MD, PhD, professor, Department of Regenerative Medicine at Yokohama City University.

Designed and manufacture of the Elplasia custom micro well plate involved a collaboration with Kuraray Co., Ltd., in Japan.

Funding support for the research and development came in part from the Research Center Network Grant for Realization of Regenerative Medicine (Japan Agency for Medical Research and Development), PRESTO (Japan Science and Technology Agency), Grantsin-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24106510, 24689052, 21249071 and 25253079), from the Specified Research Grant of the Takeda Science Foundation and from the Japan IDDM network. Takebe is a New York Stem Cell Foundation - Robertson Investigator.

Takebe and Taniguchi have served on scientific advisory boards for Healios Inc., in Japan, a collaborator on the current study.

Cincinnati Children's Hospital Medical Center

Related Liver Disease Articles:

New study: Unsaturated fat associated with fatty liver disease
As the obesity epidemic continues, new data shed light on which nutrients and what quantity of those nutrients promote health or disease.
Scientists reverse mechanism of fatty liver disease
Researchers have identified the mechanism which causes a build-up of fat in the liver in a disease affecting one in five in the UK -- and were able to reverse it in a mouse model.
Zinc may hold key to fighting liver disease
New research from Sydney's Westmead Institute for Medical Research highlights the potential for zinc to be used as a simple and effective therapeutic against viral infections such as hepatitis C and influenza.
All heart patients have some liver disease after Fontan surgery
Patients who undergo the Fontan operation as children for a complex congenital heart defect are at risk of developing progressive liver fibrosis, a buildup of fibrous deposits, as a result of the circulation created by the surgery.
Intestinal fungi worsen alcoholic liver disease
Liver cirrhosis is the 12th leading cause of mortality worldwide and approximately half of those deaths are due to alcohol abuse.
Inflammatory signature of nonalcoholic fatty liver disease
A team of investigators led by Rohit Kohli, MBBS, MS, of Children's Hospital Los Angeles, has identified key inflammatory cells involved in nonalcoholic fatty liver disease.
Stool microbes predict advanced liver disease
Nonalcoholic fatty liver disease (NAFLD) -- a condition that can lead to liver cirrhosis and cancer -- isn't typically detected until well advanced.
A new index for the diagnosis of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease has become a global epidemic. There is not only a great interest worldwide to understand the causes and consequences of fatty liver disease, but also to diagnose fatty liver disease at an early stage.
Unveiling the biology behind nonalcoholic fatty liver disease
EPFL scientists have discovered a new biological mechanism behind nonalcoholic fatty liver disease.
New approach to liver transplantation: Using a damaged liver to replace a dying liver
There's new hope for patients with liver disease who are waiting for a donor liver to become available for transplantation.

Related Liver Disease Reading:

What You Must Know About Liver Disease: A Practical Guide to Using Conventional and Complementary Treatments
by Rich Snyder DO (Author)

Fatty Liver: Best Recipes And Guide To Prevent, Cure And Reverse Fatty Liver Diseases, Lose Weight & Live Healthier
by Alejandro Pierce (Author)

Skinny Liver: A Proven Program to Prevent and Reverse the New Silent Epidemic--Fatty Liver Disease
by Kristin Kirkpatrick (Author), Ibrahim Hanouneh (Author)

The First Year: Cirrhosis: An Essential Guide for the Newly Diagnosed
by James L. Dickerson (Author), Fredric Regenstein (Foreword)

The Liver Healing Diet: The MD's Nutritional Plan to Eliminate Toxins, Reverse Fatty Liver Disease and Promote Good Health
by Michelle Lai (Author), Asha Kasaraneni (Author)

Schiff's Diseases of the Liver
by Eugene R. Schiff (Editor), Willis C. Maddrey (Editor), K. Rajender Reddy (Editor)

Healing Fatty Liver Disease: A Complete Health and Diet Guide, Including 100 Recipes
by Dr. Maitreyi Raman MD MSc FRCPC (Author), Angela Sirounis BSc RD (Author), Jennifer Shrubsole BSc RD (Author)

Zakim and Boyer's Hepatology: A Textbook of Liver Disease, 7e
by Arun J. Sanyal MBBS MD (Author), Thomas D. Boyer MD (Author), Norah A Terrault MD MPH (Author), Keith D Lindor MD (Author)

Sleisenger and Fordtran's Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, 10e (Gastrointestinal & Liver Disease (Sleisinger/Fordtran))
by Mark Feldman MD (Author), Lawrence S. Friedman MD (Author), Lawrence J. Brandt MD (Author)

Fatty Liver: You Can Reverse It
by Sandra Cabot M.D. (Author), Thomas Eanelli MD (Author)

Best Science Podcasts 2018

We have hand picked the best science podcasts for 2018. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Why We Hate
From bullying to hate crimes, cruelty is all around us. So what makes us hate? And is it learned or innate? This hour, TED speakers explore the causes and consequences of hate — and how we can fight it. Guests include reformed white nationalist Christian Picciolini, CNN commentator Sally Kohn, podcast host Dylan Marron, and writer Anand Giridharadas.
Now Playing: Science for the People

#482 Body Builders
This week we explore how science and technology can help us walk when we've lost our legs, see when we've gone blind, explore unfriendly environments, and maybe even make our bodies better, stronger, and faster than ever before. We speak to Adam Piore, author of the book "The Body Builders: Inside the Science of the Engineered Human", about the increasingly amazing ways bioengineering is being used to reverse engineer, rebuild, and augment human beings. And we speak with Ken Thomas, spacesuit engineer and author of the book "The Journey to Moonwalking: The People That Enabled Footprints on the Moon" about...